Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Forner

Showing results (41-50 of 103) with videos related to

Pageof 11
Sort By:
European Radiology|March 7, 2025
Diagnostic performance of contrast-enhanced US in small liver nodules not conclusively characterized after MRI in cirrhotic patientsBelén Saborido, Anna Darnell, Alejandro Forner, et al.
JHEP Reports : Innovation in Hepatology|December 24, 2025
Epidemiology, clinical, molecular features, and prognosis of early-onset biliary tract cancer: A systematic review and meta-analysisErman Akkus, Antonella Cammarota, Laura Izquierdo-Sanchez, et al.
Gut|January 31, 2012
Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinomaSilvia Tremosini, Alejandro Forner, Loreto Boix, et al.
BMC Cancer|May 19, 2010
A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinomaTim F Greten, Alejandro Forner, Firouzeh Korangy, et al.
Hepatology (Baltimore, Md.)|June 1, 2010
Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasoundRamón Vilana, Alejandro Forner, Luis Bianchi, et al.
Annals of Hepatology|December 26, 2025
A three-gene resistome signature as a prognostic tool in hepatocellular carcinomaAnabel Sanchez-Martin, Rocio I R Macias, Luis Muñoz-Bellvís, et al.
Hepatology (Baltimore, Md.)|November 15, 2015
Prospective validation of ab initio liver transplantation in hepatocellular carcinoma upon detection of risk factors for recurrence after resectionJoana Ferrer-Fàbrega, Alejandro Forner, Alexandre Liccioni, et al.
Journal of Hepatology|June 26, 2024
Histological predictors of aggressive recurrence of hepatocellular carcinoma after liver resectionCarla Fuster-Anglada, Ezequiel Mauro, Joana Ferrer-Fàbrega, et al.
Journal of Hepatology|February 9, 2012
Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial designMarta Burrel, María Reig, Alejandro Forner, et al.
Journal of Hepatology|July 23, 2020
Hepatitis C-related cirrhosis will be a marginal cause of hospital admissions by 2025Sergio Rodríguez-Tajes, Anna Pocurull, Joaquín Castillo, et al.
Pageof 11

Showing results (41-50 of 103) with videos related to

Sort By:
Pageof 11
European Radiology|March 7, 2025
Diagnostic performance of contrast-enhanced US in small liver nodules not conclusively characterized after MRI in cirrhotic patientsBelén Saborido, Anna Darnell, Alejandro Forner, et al.
JHEP Reports : Innovation in Hepatology|December 24, 2025
Epidemiology, clinical, molecular features, and prognosis of early-onset biliary tract cancer: A systematic review and meta-analysisErman Akkus, Antonella Cammarota, Laura Izquierdo-Sanchez, et al.
Gut|January 31, 2012
Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinomaSilvia Tremosini, Alejandro Forner, Loreto Boix, et al.
BMC Cancer|May 19, 2010
A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinomaTim F Greten, Alejandro Forner, Firouzeh Korangy, et al.
Hepatology (Baltimore, Md.)|June 1, 2010
Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasoundRamón Vilana, Alejandro Forner, Luis Bianchi, et al.
Annals of Hepatology|December 26, 2025
A three-gene resistome signature as a prognostic tool in hepatocellular carcinomaAnabel Sanchez-Martin, Rocio I R Macias, Luis Muñoz-Bellvís, et al.
Hepatology (Baltimore, Md.)|November 15, 2015
Prospective validation of ab initio liver transplantation in hepatocellular carcinoma upon detection of risk factors for recurrence after resectionJoana Ferrer-Fàbrega, Alejandro Forner, Alexandre Liccioni, et al.
Journal of Hepatology|June 26, 2024
Histological predictors of aggressive recurrence of hepatocellular carcinoma after liver resectionCarla Fuster-Anglada, Ezequiel Mauro, Joana Ferrer-Fàbrega, et al.
Journal of Hepatology|February 9, 2012
Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial designMarta Burrel, María Reig, Alejandro Forner, et al.
Journal of Hepatology|July 23, 2020
Hepatitis C-related cirrhosis will be a marginal cause of hospital admissions by 2025Sergio Rodríguez-Tajes, Anna Pocurull, Joaquín Castillo, et al.
Pageof 11